25-OR: ADA Presidents' Select Abstract: Preclinical Evaluation of TYK2 Inhibitors in Type 1 Diabetes
FAROOQ SYED(Indianapolis Zoo), Carmella Evans‐Molina(Diabetes Australia), Kara S. Orr(Indiana University – Purdue University Indianapolis), Maria Inês Alvelos(Université Libre de Bruxelles), Ângela Castela(Université Libre de Bruxelles), Alexandra Coomans de Brachène(Université Libre de Bruxelles), Arnaud Zaldumbide(Leiden University Medical Center), Staci A. Weaver(Indiana University – Purdue University Indianapolis), Sofia Thomaidou, DECIO L. EIZIRIK(Indianapolis Zoo), Donalyn Scheuner(Indiana Biosciences Research Institute), Garrick Chang(Indiana University Indianapolis), Jyoti Rana(Indiana University – Purdue University Indianapolis), Olivia Ballew(Indiana Biosciences Research Institute), Jing Liu(Purdue University West Lafayette), Stéphane Demine(Indiana Biosciences Research Institute), Chih‐Chun Lee(Diabetes Australia), KENTARO YAMADA(Indianapolis Zoo)
Cited by 1
Related Papers
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in <i>db/db</i> Mice
|Diabetes|2018|385
Inhibiting glycogen synthesis prevents lafora disease in a mouse model
|Annals of Neurology|2013|111
The praxis of acknowledgement: from bibliometrics to influmetrics
|Revista española de Documentación Científica|1995|77
Profiling of RNAs from Human Islet-Derived Exosomes in a Model of Type 1 Diabetes
|International Journal of Molecular Sciences|2019|60
Brain glycogen supercompensation in the mouse after recovery from insulin‐induced hypoglycemia
|Journal of Neuroscience Research|2011|47